AHRQ: Anticoagulant prescriptions in U.S. total $900M+ in 2007

In 2007, a reported 4.2 million Americans purchased 27.9 million anticoagulant prescriptions, totaling $905.2 million, according to a survey published by the Agency for Healthcare Research and Quality (AHRQ).

The report found about 10 percent of Americans 75 and older and 6 percent of Americans between the ages of 65 and 74 used one or more blood thinners in 2007. In contrast, less than 1 percent of people younger than 65 used a blood thinner.

    Of those who took anticoagulants, 74 percent had cardiac conditions, 40.3 percent underwent surgery, 30.2 percent were diagnosed with cancer and 27.6 percent had diabetes.

    One-quarter of patients prescribed the drugs showed signs of dysrhythmia and a range of 4 to 6 percent of patients prescribed anticoagulants had hypertension or high cholesterol.

    The survey found that per adult the average annual expenditure of anticoagulant drug purchases was $213.16, with an average annual out-of-pocket cost of $91.37.

    Of the total prescriptions, 19.3 percent were generics with an average expenditure and mean out-of-pocket cost per per perscription of $18.17 and $7.30, respectively. Of the total prescriptions, 8.5 million were brand-name drugs with an average expenditure and mean out-of-pocket cost per perscription of $64.96 and $28.95, respectively.

    AHRQ, part of the U.S. Department of Health and Human Services, accumulated these data from the Medical Expenditure Panel Survey.

    Around the web

    Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
     

    The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

    Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.